Option chain shows key data for Ainos's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Ainos.

Ainos (NASDAQ:AIMD) Stock, Option Chain

Ainos

Ainos Inc is engaged in developing biologics for the treatment of human and animal diseases. The company mainly focuses on the research of the treatment of human disease indications, particularly influenza, hepatitis C, thrombocytopenia, and other indications using natural human interferon-alpha that is administered in a proprietary low-dose oral form. Its product pipeline includes VELDONA Pet cytoprotein supplements for pets, VELDONA human therapeutics for clinical use, and telehealth-friendly POCTs powered by the AI Nose technology platform.

movers image

News

Pre-Market Outlook

Markets

Movers

Trading Ideas

ADAP

AILE

AIMD

ANTE

CMAX

ESPR

MASSIVE INTERACTIVE NV by Massive Interactive, Inc.

HUGE

HUMA

LGMK

MMAT

NDRA

PSIG

SNOA

TNON

YMAB

Why Ainos Shares Are Trading Higher By Around 38%; Here Are 20 Stocks Moving Premarket

Penny Stocks

Small Cap

Intraday Update

AEVA

AIRE

Amplify YieldShares Oil Hedged MLP Income ETF

AMLX

AQST

ASLE

BBAI

BREA

CERO

COOK

COST

CRML

CRMT

CTOS

DOGZ

DOMO

EGOX

GIFI

GRFS

GROM

IMRN

JYNT

MIRA

MOBX

MRVL

PRCH

PRTS

RDFN

RDNT

REFR

RWAY

SWBI

SWVL

VIRX

WLDN

Shares of  Marvell Technology, Inc. (NASDAQ: MRVL) fell sharply during Friday’s session after the company reported fourth-quarter financial results and issued weak Q1 guidance.

Why Marvell Technology Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday&#39;s Mid-Day Session

Earnings

Eurozone

Commodities

Global

U.S. stocks traded higher this morning, with the Nasdaq Composite gaining over 50 points on Friday.

Following the market opening Friday, the Dow traded up 0.04% to 38,805.52 while the NASDAQ rose 0.41% to 16,339.39. The S&amp;P 500 also rose, gaining, 0.23% to 5,169.38.

Nasdaq Gains Over 50 Points; US Economy Adds 275,000 Jobs In February

Ainos Inc

Press Releases

Ainos Announces IRB Approval for Sjögren's Syndrome Clinical Study at Shuang Ho Hospital, Affiliated with Taipei Medical University, and Plans to Initiate New Phase of Treatment Evaluation in Q1 2025

Water Tower Research Highlights IRB Approval for the Ainos VELDONA Clinical Sjogren's Trial Alongside 3Q24 Earnings and Developments

Water Tower Research Underscores Ainos' Partnership With Taiwan Tanabe Seiyaku for VELDONA Manufacturing and Marketing

Ainos Joins Webull Corporate Connect Service Platform to Enhance Investor Engagement

Smell the Future: Ainos Elevates Health and Technology With AI Nose and VELDONA

CORRECTION BY SOURCE: Smell the Future: Ainos Elevates Health and Technology With AI Nose and VELDONA

Ainos Unveils AI Nose for Robotics: Invites Global Robotics Companies to Join Forces in Shaping the Future of Smell-Enabled Robots

Legal

Ainos Granted 180-Day Extension by Nasdaq to Regain Compliance With Minimum Bid Price Rule

Water Tower Research Spotlights Ainos' AI Nose Programs and Strategic Milestones for 2025

Ainos Achieves Major Breakthrough: Japan Patent Approval for VELDONA Redefines Antiviral Innovation

AIMDW

AIM ImmunoTech

Apollomics Inc. - Class A Ordinary Shares

Apollomics

Aptorum Group Limited - Class A Ordinary Shares

Aptorum Gr

BioCardia

Brainstorm Cell Therapeutics Inc. - Common Stock

Brainstorm Cell

bioAffinity Technologies, Inc. - Common Stock

bioAffinity Technologies

BioRestorative Therapies, Inc. - Common Stock

BioRestorative Therapies

BioXcel Therapeutics, Inc. - Common Stock

BioXcel Therapeutics

Can-Fite Biopharma Ltd Sponsored ADR (Israel)

Can Fite Biofarma

Creative Medical Technology Holdings, Inc. - Common Stock

Creative Medical Tech

Carmell

Cyclerion Therapeutics, Inc. - Common Stock

Cyclerion Therapeutics

Dermata Therapeutics, Inc. - Common Stock

Dermata Therapeutics

Dogwood Therapeutics, Inc. - Common Stock

Dogwood Therapeutics

Ensysce Biosciences

Immuron Limited - American Depositary Shares

Immuron

Indaptus Therapeutics, Inc. - Common Stock

Indaptus Therapeutics

Klotho Neurosciences, Inc. - Common Stock

Klotho Neurosciences

Phio Pharmaceuticals Corp. - Common Stock

Phio Pharma

Portage Biotech

Sunshine Biopharma

SILO Pharma

Silexion Therapeutics Corp - Ordinary Shares

Silexion Therapeutics

Turnstone Biologics

XTL Biopharmaceuticals Ltd. - American Depositary Shares

XTL Biopharmaceuticals

Comments

Ainos

Ainos (AIMD) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga